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WHAT THIS PAPER ADDS
 Ultrasound guidance for invasive anaesthetic procedures may improve efﬁcacy, facilitate performance and reduce risk of
complications. So far, cervical plexus blockade guided by ultrasound has not been evaluated on patients undergoing carotid artery
surgery. The ultrasound-guided locoregional anaesthesia investigated in this study provides good-quality analgesia with limited
need for intra-operative supplementation and is an attractive choice for carotid endarterectomy.a r t i c l e i n f o
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Introduction: Ultrasound guidance is increasingly used for invasive anaesthetic procedures to improve
efﬁcacy, facilitate performance and reduce risk of complications. Herein, we present a simple approach to
ultrasound-guided locoregional anaesthesia for patients undergoing eversion carotid endarterectomy.
Methods: At the level of the base of the carotid bifurcation, the needle was inserted at the lateral border
of the sternocleidomastoid muscle and, guided by ultrasound, advanced 0.5e1 cm posterolateral to the
carotid artery, where ropivacaine (7.5 mg ml1) was injected. During retraction of the needle, additional
local anaesthetic was administered beneath the sternocleidomastoid muscle and, ﬁnally, subcutaneous
inﬁltration along the surgical incision line was performed.
The primary study end point was the amount of additional ropivacaine (7.5 mg ml1) provided intra-
operatively. Secondary measures included the occurrence of puncture-related complications and the
adverse effects to locoregional anaesthesia.
Results: Sixty consecutive patients admitted for primary carotid endarterectomy were prospectively
included. The volume of administered ropivacaine for locoregional anaesthesia and subsequent intra-
operative supplementation was 31.7  3.5 and 1.9  2.5 ml, respectively. There were no conversions
to general anaesthesia. Intravascular or subarachnoid injection of local anaesthetic did not occur, and
symptoms of local anaesthetic systemic toxicity did not present. Related to the blockade, hoarseness
(72%), Horner syndrome (37%), cough (20%), facial palsy (13%) and dysphagia (12%) were observed and
resolved on the ﬁrst postoperative day.
Conclusions: This observational study demonstrates that the described ultrasound-guided locoregional
anaesthesia is suitable for eversion carotid endarterectomy and the amount of supplemental anaesthetic
during the surgery is low.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Regional anaesthesia for carotid endarterectomy (CEA) is
commonly achieved by the use of cervical plexus blockade (CPB).
While superﬁcial CPB1 is a simple subcutaneous inﬁltration alongtment of Anesthesia 2041,
mark. Tel.: þ45 35450802.
ail.com, dr.martusevicius@
ciety for Vascular Surgery. Publishethe posterior border of the sternocleidomastoid muscle (SCM),
a deep CPB2,3 is essentially a paravertebral block of the C2, C3 and
C4 spinal nerves. Local anaesthetic (LA) injected between the
superﬁcial and deep cervical fascia posteriorly to the SCM is
considered to spread towards the roots of cervical nerves and this
block is classiﬁed as intermediate.4 By classical approach, LA is
administered blindly and the procedure may be a challenging task
with potential risk of serious puncture-related complications,d by Elsevier Ltd. All rights reserved.
Figure 1. The local anaesthetic injected close to the carotid artery. LA e local anaes-
thetic (yellow circle), CCA e common carotid artery, IJV e internal jugular vein, SCM e
sternocleidomastoid muscle.
Figure 2. Diffuse spread of local anaesthetic injected beneath the sternocleidomastoid
muscle. LA e local anaesthetic (yellow circle), CCA e common carotid artery, IJV e
internal jugular vein, SCM e sternocleidomastoid muscle.
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landmarks.
In the past decade, ultrasound guidance for invasive anaesthetic
procedures has been increasingly used and become common in
daily clinical practice for vascular access and peripheral nerve
blocks. Since ultrasonography enables real-time imaging of
anatomic structures beneath the skin, needle position and spread of
LA, the use of ultrasound may enhance efﬁcacy of the regional
anaesthesia and minimise potential risk of puncture-related
complications.
Ultrasound-guided blocks of the cervical plexus are
described5,6; however, these techniques are not evaluated on
patients undergoing CEA.We considered an alternative ultrasound-
guided approach with LA administered close to the carotid artery
and beneath the SCM e the anatomical structures easily visualised
by ultrasound. Since the ultrasound-guided central line placement
is now a widely accepted practice, most anaesthesiologists are
accustomed to using the ultrasound in the neck region, and the
technique is easily adoptable by all. Herein, we report the efﬁcacy
and the safety of such a method in a prospective observational
study design.
Methods
The study was evaluated by The Scientiﬁc Ethics Committee of
the Capital Region of Denmark (Journal no. H-2-2010-062) and
considered as not requiring ethical approval since it was directed
to quality control of a clinical procedure, which is part of standard
care at our hospital. Informed consent was obtained from all
patients.
On patient’s arrival to the operating theatre, a peripheral venous
line was established and monitoring included peripheral pulse
oximetry, 3-lead electrocardiography and invasive blood pressure
via a radial artery catheter connected to a monitoring kit (Edwards
Lifesciences, Unterschleissheim, Germany) positioned at the level
of the heart. For mild sedation during administration of the block,
remifantanil was infused intravenously at 0.05 mg kg1 min1. With
the patient positioned supine and the head facing away from the
side to be anaesthetised, the skin of the lateral neck was dis-
infected. Sterilely prepared linear ultrasound probe (12L-RS,
4e12 MHz, GE Healthcare, Wisconsin, USA) was positioned just
above the clavicle to identify the common carotid artery (CCA) in
B-mode and moved cranially to the base of bifurcation. At this
level and at the lateral border of the SCM, the needle (Stimuplex
D 0.71  80 mm; B. Braun Melsungen AG, Melsungen, Germany)
was advanced in-plane to the ultrasound beam and placed
0.5e1 cm posterolateral to the bifurcation of the CCA scanned in
short axis (Fig. 1). Following negative aspiration of blood, ropiva-
caine (7.5 mg ml1) was injected to aim for a half-moon-shaped
spread of the LA. Upon needle retraction, additional LA was
administered beneath the SCM (Fig. 2) and, ﬁnally, subcutaneous
inﬁltration along the surgical incision line was performed.
The sensory block at the surgical site was assessed by pinprick
with a 24-gauge needle. The surgical incision was made along the
anterior border of the SCM and the carotids were exposed by
careful dissection. The atheromatous plaque was removed from the
lumen of the carotid artery by eversion,7 which is a standard
technique at our centre. During surgery, communication with the
patient was maintained at all times and the patient was directed to
indicate pain by hand gesture. Reports of pain prompted the
surgeon to inﬁltrate ropivacaine (7.5 mg ml1) within the surgical
ﬁeld.
The primary outcome measure of the study was the amount of
supplemental ropivacaine used by the surgeon for adequate anal-
gesia. Secondary measures included the occurrence of puncture-related complications (subarachnoid and intravascular injection
and local anaesthetic systemic toxicity) and the adverse effects to
locoregional anaesthesia (breathing difﬁculty, dysphagia, hoarse-
ness, coughing, Horner syndrome, facial palsy and arm weakness).
The survey of patient and surgeon satisfaction with provided
anaesthesia was conducted for the ﬁrst 40 cases (very satisﬁed,
satisﬁed, less satisﬁed and unsatisﬁed).
Statistical analysis was performed using SPSS version 19
statistical software (SPSS Inc., Chicago, IL, USA). The
ManneWhitney U test for continuous non-parametric data and
Pearson’s chi-square test for categorical data were used to
compare the group of patients who required intra-operative
supplementation and those who did not. Data are presented as
means  standard deviation (SD) for continuous data and
numbers (percentage) for categorical data. A value of P < 0.05 was
considered as statistically signiﬁcant.
Table 1
Patients’ characteristics.
Age (years) 67.2  8.6
Male 44 (73%)
Female 16 (27%)
Body mass index (kg/m2) 27.2  4.4
ASA II 22 (37%)
ASA III 38 (63%)
Arterial hypertension 40 (67%)
Coronary artery disease 14 (23%)
Diabetes mellitus 11 (18%)
Chronic obstructive pulmonary disease 9 (15%)
Previous myocardial infarct 8 (13%)
Heart valve disease 4 (7%)
Renal disease 2 (3%)
Heart insufﬁciency (EF < 35%) 1 (2%)
Mono anti-platelet therapy 19 (32%)
Dual anti-platelet therapy 41 (68%)
Left side of surgery 23 (38%)
Right side of surgery 37 (62%)
Values are mean  SD or number with percentage.
Table 3
Adverse effects to locoregional anaesthesia.
Hoarseness 43 (72%)
Horner syndrome 22 (37%)
Cough 12 (20%)




Values are number with percentage.
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From July 2009 to August 2010, 60 consecutive patients in
American Society of Anesthesiologist physical status classiﬁcation
Class II and III (Table 1) underwent CEA under ultrasound-guided
locoregional anaesthesia (UGLRA). All patients were symptomatic
with carotid-territory transient ischaemic attacks or minor strokes
and had carotid artery stenosis ranging from 50% to 95%. None of
the patients had prior irradiation or intervention on the neck and
there were only primary CEA. For stroke prevention, mono (32%) or
dual (68%) anti-platelet therapy was given to all patients.
The mean total volume of ropivacaine (7.5 mg ml1) adminis-
tered for UGLRA was 31.7  3.5 ml and distributed as follows:
10.9  3.0, 12.7  3.2 and 8.6  2.6 ml for the paracarotid inﬁltra-
tion, beneath the SCM, and along the surgical incision line,
respectively. Procedural time was approximately 3e5 min
excluding prescanning and preparation time.
Following the blockade, surgery was initiated within 23 6 min
and subsequently administered volume of additional ropivacaine
(7.5 mg ml1) was 1.9  2.5 ml per procedure. There were no
conversions to general anaesthesia. Intra-operative supplementa-
tionwith LAwas required in 47% of patients (n ¼ 28). Administered
dose of ropivacaine for the UGLRA was similar in the group of the
patients who required supplementation and those who did not
(32.1  4.2 vs. 31.3  2.9 ml, P ¼ 0.733). There was no difference in
body mass index (P ¼ 0.953), age (P ¼ 0.994), sex (P ¼ 0.391), ASA
score (P ¼ 0.886), operating time (P ¼ 0.067) and side of surgery
(P ¼ 0.887) between the two groups (Table 2).
The test for aspiration of blood was negative in all cases. There
was no evidence of intravascular or subarachnoid LA injection andTable 2
Comparison of variables between the group of patients who required intra-operative
supplementation with ropivacaine and those who did not.
Variable Supplementation
required (N ¼ 28)
Supplementation not




32.1  4.2 31.3  2.9 P ¼ 0.733
BMI (kg/m2) 27.3  4.3 27.1  4.6 P ¼ 0.953
Age (years) 66.9  8.3 67.5  9.0 P ¼ 0.994
Male/Female 22/6 22/10 P ¼ 0.391
ASA II/III 10/18 12/20 P ¼ 0.886
Operating time (min) 77 67 P ¼ 0.067
L/R side of surgery 11/17 12/20 P ¼ 0.887
Values are mean  SD or number.local anaesthetic systemic toxicity did not occur. Adverse effects to
locoregional anaesthesia are presented in Table 3. Hoarseness
occurred in most patients, but it was tolerated, as was the case with
dysphagia. Some patients felt the need to cough, but it did not affect
the surgery. When the patients were re-examined on the day
following surgery, all adverse effects were fully recovered.
Patient and surgeon satisfaction score with UGLRA is presented
in Table 4.
An intra-operative shunt placement was required in one case.
One patient died as a result of intracerebral haemorrhage associ-
ated with cerebral hyperperfusion syndrome. Other postoperative
complications included one ischaemic stroke, one acute myocardial
infarction and two episodes of bleeding. No postoperative infec-
tions were registered at the 6-week check-up.
Discussion
At our hospital, the standard of care for CEA is regional anaes-
thesia, except the cases, when a patient is not able to comply or
refuses to be awake during surgery. In 2009, we replaced blind
technique of the traditional combined deep and superﬁcial CPB by
an ultrasound-guided approach. Subsequently, it was our clear
impression that the amount of supplemental LA provided by the
surgeon became substantially lower.
The present study of 60 consecutive patients was conducted
following a learning period of 10 patients and demonstrated that
the topical anaesthetic supplementation was required in almost
half of the cases (47%); however, the mean volume of additional LA
per procedure (2 ml) was quite low. Intra-operative administration
of LA was mainly due to pain/discomfort in the upper part of the
operation ﬁeld or at the mandibular angle as a result of a surgical
traction. In comparison, the incidence of anaesthetic supplemen-
tation during CEA reported in the literature8e11 varies from 32% to
100% at a volume raging from 7 to 10 ml. Disadvantages of
supplemental administration of LA in considerable amount include
prolonged operative time and provoked tissue oedema that
aggravates the surgical conditions. In addition, patient anxiety due
to lack of adequate analgesia may lead to further unnecessary
administration of LA that increases the risk of local anaesthetic
systemic toxicity.
The administered dose of ropivacaine (7.5 mg ml1) for the
UGLRA was not standardised and depended on patient character-
istics and co-morbidity, but did not exceed 40 ml. We did not
observe any symptoms of local anaesthetic systemic toxicity.
Local inﬁltration of the carotid sheath during surgery is often
needed, as it has a cranial nerve supply from vagal nerve branchesTable 4
Patient and surgeon satisfaction score with provided anaesthesia.
Very satisﬁed Satisﬁed Less satisﬁed Unsatisﬁed
Patient 22 (55%) 16 (40%) 2 (5%) 0
Surgeon 27 (67.5%) 13 (32.5%) 0 0
Values are number with percentage.
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thetisedby the classical CPB.12 Basedon this fact,weconsidered, that
LA delivered close to the carotid sheath is reasonable and may
improve the efﬁcacy of the locoregional anaesthesia. Furthermore,
Roessel et al.13 noted that in ultrasound-guided high interscalene
brachial plexus block for CEA with spread of anaesthetics towards
the carotid artery there is limited need for supplemental LA.
Although no changes in heart ratewere observed during injection of
LA close to the bifurcation of the CCA, awareness must be raised as
potential stimulation of the carotid sinus can provoke bradycardia.
Conversely, preoperative paracarotid inﬁltration with LA may be
protective in the course of surgical dissection and manipulation.
Using human cadavers, Pandit and colleagues14 demonstrated
that the deep cervical fascia is permeable. Therefore, we considered
that LA injected beneath the SCM enters the deep cervical space
and affects C2eC4 spinal nerve roots. Such a cervical plexus block,
when LA is delivered below the superﬁcial cervical fascia, is clas-
siﬁed as intermediate.4 Nevertheless, administration of LA by the
described technique in the close proximity of the operation ﬁeld
may act as pure local inﬁltration.
In the neck region, the density of the blood vessels and nerves is
high, and a peripheral nerve block that is guided by external body
landmarks involves a potential risk for puncture-related compli-
cations. Although inadvertent subarachnoid and intravascular
injection of LA was found in only 0.25% of the patients subjected to
classical deep CPB,15 it is a serious complication that may have
a consequence for postoperative morbidity and mortality. In addi-
tion, in a prospective study of 1000 superﬁcial and deep CPB, Davies
et al.16 reported that aspiration of blood occurs in 30%. The majority
of the patients undergoing CEA are usually treated with anti-
platelet drugs and puncture of the blood vessels could lead to
local haemorrhage that might affect the surgical conditions.
Systemic reviews17,18 demonstrate that ultrasound guidance for
peripheral nerve blocks in patients undergoing orthopaedic surgery
can reduce the incidence of vascular puncture. In the present study,
the test for aspiration of blood was negative in all cases and this
technique may be considered as safe even in patients on dual anti-
platelet therapy.
The most of transient adverse effects related to the locoregional
anaesthesia are probably caused by LA administered close to the
carotid artery, where the recurrent laryngeal nerve and cervical
sympathetic branches are affected. Thus, the use of LA at lower
concentration and/or volume for the paracarotid inﬁltration may
decrease the incidence of adverse effects. At the moment, we use
ropivacaine 5 mg ml1 and our impression is that the quality of the
block remains the same while adverse effects seem to be reduced.
Given the high incidence of hoarseness (72%) associated with this
blocking technique, it would be reasonable to consider preopera-
tive laryngoscopy to evaluate function of the vocal cords in case of
prior irradiation or surgery on the contralateral side of the neck.
Conclusions
This observational study demonstrates that the described
UGLRA is suitable for eversion CEA and the amount ofsupplemental LA during the surgery is low. Randomised clinical
trials need to be conducted to compare efﬁcacy and safety of this
technique with traditional CPB that is guided by anatomical
landmarks.Funding
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